繁體
加載中...
登入 /註冊
搜索...
繁體
$2,380體驗「Juvederm®長效透明質酸」
對抗初老，就要擺脫皺紋、逆轉下垂! No.1最長效輪廓改善療程¹ Juvéderm® 長效透明質酸療程以不同濃度透明質酸，全方位改善改善膚質及輪廓²⁻⁵，針對下垂、凹陷、顯老紋路、下巴後縮、下顎線模糊 等問題³，全方位展現年輕感，即時提昇豐盈輪廓，長效達5年！⁶ 採用國際專利技術，令透明質酸和肌膚完美融為一體⁷⁻⁸，讓你持續展現真實自然美！
全球銷量突破1億⁹，Juvéderm® 長效透明質酸療程全線法國製作，榮獲美國FDA¹⁰及歐盟CE¹¹認證，經科研實證，97%用家滿意並樂意推薦¹²！全面實現飽滿、提昇、淡紋、亮眼、彈滑，締造自然美感輪廓！
Juvéderm® 長效透明質酸功效
• VOLBELLA 擊退淚溝型黑眼圈，緊緻撫平眼袋眼紋• VOLIFT 改善額頭凹陷、法令紋、木偶紋等，適用於較多表情位置
• VOLITE 長效注水提亮膚質，綻放水潤彈亮肌
• VOLUMA 提升中面輪廓，豐盈太陽穴、蘋果肌等
• VOLUX 透明質酸締造下巴鮮明下顎線，展現零死角V面
2024下半年正貨認可醫療中心證書
2015-2023連續9年
十大最高銷售醫學美容中心
十大最高銷售醫學美容中心
¹De Maio M, et al. Plast Reconstr Surg. 2017 Oct;140(4):540e-550e.
² De Maio M, et al. Plast Reconstr Surg. 2017 Aug;140(2):265e-276e.
³ De Maio M, et al. Plast Reconstr Surg. 2017 Oct;140(4):540e-550e.
⁴ De Maio M. et. al. Plast Reconstr Surg. 2017 Sep;140(3):393e-404e.
⁵ Ogilvie P et al. J Cosmetic Dermatol. 2019;00:1-6.
⁶ Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9
⁷ Hee CK et al. Dermatol Surg. 2015;41(Suppl 1):S373-381
⁸ Allergan Data on File. ALL-JUV-210477. Juvéderm® tissue integration images.
⁹ Allergan. Data on File. REF-96563. FILLERS GLOBAL NUMBER OF SYRINGES. May 2022. 100 million Juvéderm® syringes manufactured worldwide from 2004 to April 2022.
¹⁰ VOLUXTM, VOLUMA®, VOLIFT®及VOLBELLA® (approval as VOLUXTM XC, VOLUMA® XC, VOLLURE® XC and VOLBELLA® XC in US) 均獲得美國FDA認證. U.S. Food and Drug Administration, Department of Health & Human Services. Juvéderm VOLUX XC approval letter P110033/S065, July 2022; Juvéderm VOLUMA XC approval letter P110033/S047, Jun 2020; Juvéderm VOLLURE XC approval letter P110033/S020, Mar 2017; Juvéderm VOLBELLA XC approval letter P110033/S053, May 2021.
¹¹ VOLUX™, VOLUMA®, VOLIFT®, VOLBELLA®及VOLITE™均獲得歐盟CE認證. European Commission, Juvéderm hyaluronic acid based medical devices. EC certificate number: 3824296CE02; 3824296CE05; 3824296CE06; 3824296CE08; 3824296CE09, Mar 2020.
¹² Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9
² De Maio M, et al. Plast Reconstr Surg. 2017 Aug;140(2):265e-276e.
³ De Maio M, et al. Plast Reconstr Surg. 2017 Oct;140(4):540e-550e.
⁴ De Maio M. et. al. Plast Reconstr Surg. 2017 Sep;140(3):393e-404e.
⁵ Ogilvie P et al. J Cosmetic Dermatol. 2019;00:1-6.
⁶ Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9
⁷ Hee CK et al. Dermatol Surg. 2015;41(Suppl 1):S373-381
⁸ Allergan Data on File. ALL-JUV-210477. Juvéderm® tissue integration images.
⁹ Allergan. Data on File. REF-96563. FILLERS GLOBAL NUMBER OF SYRINGES. May 2022. 100 million Juvéderm® syringes manufactured worldwide from 2004 to April 2022.
¹⁰ VOLUXTM, VOLUMA®, VOLIFT®及VOLBELLA® (approval as VOLUXTM XC, VOLUMA® XC, VOLLURE® XC and VOLBELLA® XC in US) 均獲得美國FDA認證. U.S. Food and Drug Administration, Department of Health & Human Services. Juvéderm VOLUX XC approval letter P110033/S065, July 2022; Juvéderm VOLUMA XC approval letter P110033/S047, Jun 2020; Juvéderm VOLLURE XC approval letter P110033/S020, Mar 2017; Juvéderm VOLBELLA XC approval letter P110033/S053, May 2021.
¹¹ VOLUX™, VOLUMA®, VOLIFT®, VOLBELLA®及VOLITE™均獲得歐盟CE認證. European Commission, Juvéderm hyaluronic acid based medical devices. EC certificate number: 3824296CE02; 3824296CE05; 3824296CE06; 3824296CE08; 3824296CE09, Mar 2020.
¹² Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9